FOLH1 and posterior cortical atrophy: Throughout the past decade, a high number of novel radioligands have emerged for the diagnosis and treatment of PCa, with [177Lu]Lu-PSMA-617 as the current gold standard in compassionate use all around the globe [7,8,9].